US Stock MarketDetailed Quotes

MYGN Myriad Genetics

Watchlist
  • 21.320
  • -0.080-0.37%
Close Mar 28 16:00 ET
  • 21.320
  • 0.0000.00%
Post 16:23 ET
1.92BMarket Cap-6704P/E (TTM)

About Myriad Genetics Company

Myriad Genetics, Inc. engages in the discovery, development, and marketing of transformative molecular diagnostic tests. It operates through the Diagnostics and Other segments. The Diagnostics segment provides testing and collaborative development of testing that is designed to assess an individual's risk of developing a disease later in life. The Other segment offers testing products and services to the pharmaceutical, biotechnology and medical research industries, research and development, and clinical services for patients, and also includes corporate services. The company was founded by Walter A. Gilbert, Mark H. Skolnick, and Peter D. Meldrum in May 1991 and is headquartered in Salt Lake City, UT.

Company Profile

SymbolMYGN
Company NameMyriad Genetics
Listing Date10/06/1995
Issue Price18.00
Founded1991
CEOMr. Paul J. Diaz
MarketNASDAQ
Employees2700
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address322 North 2200 West
CitySalt Lake City
ProvinceUtah
CountryUnited States of America
Zip Code84116
Phone1-801-584-3600

Company Executives

  • Name
  • Position
  • Salary
  • Paul J. Diaz
  • Director, President and Chief Executive Officer
  • 12.79M
  • Mark Verratti
  • Chief Commercial Officer
  • 2.02M
  • Samraat S. Raha
  • Chief Operating Officer
  • --
  • Scott J. Leffler
  • Chief Financial Officer
  • --
  • Kevin Richard Haas
  • Chief Technology Officer
  • --
  • Pamela Wong
  • Chief Legal Officer
  • --
  • Dale Muzzey
  • Chief Scientific Officer
  • --
  • Natalie Munk
  • Chief Accounting Officer
  • --
  • Shereen Solaiman
  • Chief People Officer
  • --
  • Margaret Ancona
  • Senior Vice President and Chief of Staff
  • --
  • S. Louise Phanstiel
  • Chairman of the Board
  • 560.98K
  • Daniel K. Spiegelman
  • Independent Director
  • 451.48K
  • Dr. Heiner Dreismann,PhD
  • Independent Director
  • 443.48K
  • Paul M. Bisaro
  • Independent Director
  • --
  • Dr. Daniel M. Skovronsky, M.D.
  • Independent Director
  • 434.21K
  • Colleen F. Reitan
  • Independent Director
  • 430.98K
  • Dr. Lee N. Newcomer, M.D.
  • Independent Director
  • 447.98K
  • Rashmi Kumar
  • Independent Director
  • 431.53K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg